novel therapies

Image for Investment Plan for Europe: EIB Backs Italian CNS Drug Developer Newron Pharmaceuticals with up to EUR 40m
Uncategorized

Investment Plan for Europe: EIB Backs Italian CNS Drug Developer Newron Pharmaceuticals with up to EUR 40m

The European Investment Bank (EIB) and Newron Pharmaceuticals S.p.A. (Newron) (SIX: NWRN), a biophar...

30th October, 2018